Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

[U.S. News]

The guidance revisions include the estimated impact of current tariffs on U.S. products shipped to China, but not Trump's planned pharmaceutical tariffs.

Continue reading...